Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia-Reference-Cited by-同舟云学术

Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia

Published:2021-05-13 Issue:19 Volume:384 Page:1810-1823
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Tiacci Enrico¹,De Carolis Luca¹,Simonetti Edoardo¹,Capponi Monia¹,Ambrosetti Achille¹,Lucia Eugenio¹,Antolino Agostino¹,Pulsoni Alessandro¹,Ferrari Samantha¹,Zinzani Pier L.¹,Ascani Stefano¹,Perriello Vincenzo M.¹,Rigacci Luigi¹,Gaidano Gianluca¹,Della Seta Roberta¹,Frattarelli Natalia¹,Falcucci Paolo¹,Foà Robin¹,Visani Giuseppe¹,Zaja Francesco¹,Falini Brunangelo¹

Affiliation:

1. From the Institute of Hematology, Ospedale S. Maria della Misericordia, and the Department of Medicine, University of Perugia, Perugia (E.T., L.D.C., E.S., M.C., S.A., V.M.P., B.F.), the Department of Medicine, Section of Hematology, University of Verona, Verona (A. Ambrosetti), the Hematology Unit, Ospedale di Cosenza, Cosenza (E.L.), the Hematology Unit, Department of Transfusional Medicine–SIMMT, Maria Paternò-Arezzo Hospital, Ragusa (A. Antolino), the Hematology Unit, Department of Translational and...

Funder

Ministero della Salute

Fondation ARC pour la Recherche sur le Cancer

Associazione Italiana per la Ricerca sul Cancro

European Research Council

Leukemia and Lymphoma Society

Hairy Cell Leukemia Foundation

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa2031298

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detangling the Threads of Hairy Cell Leukemia, Beyond the Morphology and Into the Molecular;Clinical Lymphoma Myeloma and Leukemia;2024-09

2. Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood Malignancies;ACS Pharmacology & Translational Science;2024-07-02

3. Recommendations for the Management of Patients with Hairy-Cell Leukemia and Hairy-Cell Leukemia-like Disorders: A Work by French-Speaking Experts and French Innovative Leukemia Organization (FILO) Group;Cancers;2024-06-10

4. Hairy cell leukemia variant and WHO classification correspondence Re: 5th edition WHO classification haematolymphoid tumors: lymphoid neoplasms;Leukemia;2024-06-08

5. BRAF mutation in myeloid neoplasm: incidences and clinical outcomes;Leukemia & Lymphoma;2024-05-02